Found: 13
Select item for more details and to access through your institution.
Front & Back Matter.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 1, doi. 10.1159/000529779
- Publication type:
- Article
APPLE News.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 93, doi. 10.1159/000529383
- Publication type:
- Article
Prioritized Requirements for First-Line Systemic Therapy for Hepatocellular Carcinoma: Broad Benefit with Less Toxicity.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 1, doi. 10.1159/000528979
- By:
- Publication type:
- Article
Antibiotics Associated with Lower Survival in Hepatocellular Cancer Patients Receiving Immune Checkpoint Inhibitors Independent of Tumor Status.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 91, doi. 10.1159/000528824
- By:
- Publication type:
- Article
Tislelizumab in Patients with Previously Treated Advanced Hepatocellular Carcinoma (RATIONALE-208): A Multicenter, Non-Randomized, Open-Label, Phase 2 Trial.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 72, doi. 10.1159/000527175
- By:
- Publication type:
- Article
Was Concurrent Antibiotic Use during Immunotherapy Associated with Higher Mortality for Patients with Advanced Hepatocellular Carcinoma?
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 89, doi. 10.1159/000526944
- By:
- Publication type:
- Article
Tenofovir over Entecavir on Hepatocellular Carcinoma Prevention: Potential Mechanisms and Suitable Population.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 87, doi. 10.1159/000526917
- By:
- Publication type:
- Article
Surgical Outcomes of Laparoscopic versus Open Hepatectomy for Left Hepatocellular Carcinoma: Propensity Score Analyses Using Retrospective Japanese and Korean Individual Patient Data.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 32, doi. 10.1159/000527294
- By:
- Publication type:
- Article
Letter Regarding "Impact of Immune-Related Adverse Events on Efficacy of Immune Checkpoint Inhibitors in Patients with Advanced Hepatocellular Carcinoma".
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 85, doi. 10.1159/000526804
- By:
- Publication type:
- Article
Dietary Fat Composition Affects Hepatic Angiogenesis and Lymphangiogenesis in Hepatitis C Virus Core Gene Transgenic Mice.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 57, doi. 10.1159/000525546
- By:
- Publication type:
- Article
Hepatic Events and Viral Kinetics in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 44, doi. 10.1159/000525499
- By:
- Publication type:
- Article
Discriminatory Changes in Circulating Metabolites as a Predictor of Hepatocellular Cancer in Patients with Metabolic (Dysfunction) Associated Fatty Liver Disease.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 19, doi. 10.1159/000525911
- By:
- Publication type:
- Article
First-Line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-Analysis.
- Published in:
- Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 7, doi. 10.1159/000526639
- By:
- Publication type:
- Article